1

The Axial Spondyloarthritis (AXSPA) Treatment Market is driven by rising prevalence of AXSPA

News Discuss 
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease causes inflammation and pain in the spine and sacroiliac joints. The disease can cause back pain, stiffness, fatigue, and swelling in the involved areas. Biologics such as anti-TNF drugs like Humira, Enbrel, and Cosentyx are effective treatment options for axSpA that can help reduce inflammation and symptoms. Nonsteroid... https://sidm05911.livepositively.com/axial-spondyloarthritis-axspa-treatment-market-is-estimated-to-witness-high-growth-owing-to-advancements-in-biologics/

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story